FISCHER MEDICAL VENTURE L Fair Value
FISCHER · Chemicals · Current price ₹39.27
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹6 | 9% ROE fading to 13% over ~3 yrs, on ₹6 book |
| Relative P/E | ₹21 | EPS × 43.9 peer-median P/E |
| Graham floor | ₹8 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is FISCHER MEDICAL VENTURE L undervalued?
DocStoX estimates the fair value of FISCHER MEDICAL VENTURE L at ₹10 per share, versus the current market price of ₹39. That puts the stock about -73.7% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹6), Relative P/E (₹21), Graham floor (₹8). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹6 (bear) to ₹10 (base) to ₹21 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on FISCHER MEDICAL VENTURE L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.